Increased growth hormone response to sumatriptan challenge in adult autistic disorders

Psychiatry Research

Volumn 94, Issue 2, 2000, Pages 173-177

  Novotny, Sherie ^a   Hollander, Eric ^a   Allen, Andrea ^a   Mosovich, Serge ^a   Aronowitz, Bonnie ^a   Cartwright, Charles ^a   DeCaria, Concetta ^a   Dolgoff Kaspar, Rima ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Asperger's disorder; Autism; Growth hormone; Serotonin; Sumatriptan

Indexed keywords

PLACEBO; SEROTONIN; SEROTONIN 1D RECEPTOR; SOMATOSTATIN; SUMATRIPTAN;

ADULT; ARTICLE; ASPERGER SYNDROME; AUTISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR SENSITIVITY;

ADOLESCENT; ADULT; AUTISTIC DISORDER; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; REFERENCE VALUES; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0034656974     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00134-7     Document Type: Article

References (26)

1. Adham N., Bard J.A., Zgombick J.M., Durkin M.M., Kucharewicz S., Weinshank R.L., Branchek T.A. Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog. Neuropharmacology. 36:1997;569-576.
2. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., Young J.G. Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry. 28:1987;885-900.
3. Cook E.H., Leventhal B.L. The serotonin system in autism. Current Opinion in Pediatrics. 8:1996;348-354.
4. Cook E.H., Charak D.A., Arida J., Spohn J.A., Roizen N.J.M., Leventhal B.L. Depressive and obsessive-compulsive symptoms in the hyperserotonemic parents of children with autistic disorder. Psychiatry Research. 52:1994;25-33.
5. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology. 42:1997;666-669.
6. Gordon C.T., State R.C., Nelson J.E., Hamburger S.D., Rapoport J.L. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry. 50:1993;441-447.
7. Franceschini R., Cataldi A., Garibaldi P., Scordamaglia A., Barreca T., Rolandi E. The effects of sumatriptan on pituitary secretion in man. Neuropharmacology. 33:1994;235-239.
8. Hollander E., Cartwright C., Wong C.M., DeCaria C.M., DelGiudice-Asch G., Buchsbaum M.S., Aronowitz B. A dimensional approach to the autism spectrum. CNS Spectrums: The International Journal of Neuropsychiatric Medicine. 3:1998;22-39.
9. Hoshino Y., Yamamoto T., Kaneko M., Tachibana R., Watanabe M., Ono Y., Kumashiro H. Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiology. 11:1984;22-27.
10. 3H-serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins). Journal of Autism and Developmental Disorders. 16(1):1986;69-76.
11. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., Feingold J., Mouren-Simeoni M.C., Launay J.M. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first degree relatives. Biological Psychiatry. 45:1999;158-163.
12. Lord C., Rutter M., LeCouteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic scale for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders. 24(5):1994;659-685.
13. McBride P.A., Anderson G.M., Hertzig M.E., Sweeney J.A., Kream J., Cohen D.J., Mann J.J. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Archives of General Psychiatry. 46:1989;213-221.
14. McDougle C.J., Naylor S.T., Cohen D.J., Aghajanian G.K., Heninger G.R., Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry. 53:1996;993-1000.
15. McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H. A double-blind, placebo controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry. 53:1996;1001-1008.
16. Mehlinger R., Scheftner W.A., Pozanski E. Fluoxetine and autism [Letter]. Journal of the American Academy of Child and Adolescent Psychiatry. 29:1990;985.
17. Mota A., Bento A., Peñalva A., Pombo M., Dieguez C. Role of serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. Journal of Clinical Endocrinology and Metabolism. 80:1995;1973-1977.
18. 3H]sumatriptan-binding sites in post-mortem human brain. Cephalalagia. 16(5):1996;317-322.
19. Peroutka S.J., McCarthy B.G. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. European Journal of Psychopharmacology. 163(1):1989;133-136.
20. Perry B.D., Cook E.H. Jr., Leventhal B.L., Wainwright M.S., Freedman D.X. Platelet 5-HT 2 serotonin receptor binding sites in autistic children and their first-degree relatives. Biological Psychiatry. 30:1991;121-130.
21. Piven J., Tsai G., Nenme E., Coyle J.T., Folstein S.E. Platelet serotonin, a possible marker for familial autism. Journal of Autism and Developmental Disorders. 21:1991;51-59.
22. Potenza M.N., McDougle C.J. The role of serotonin in autism spectrum disorders. CNS Spectrums. International Journal of Neuropsychiatric Medicine. 2(5):1997;25-42.
23. Singh V.K., Singh E.A., Warren R.P. Hyperserotonemia and serotonin receptor antibodies in children with autism but not mental retardation. Biological Psychiatry. 41:1997;753-755.
24. Steingard R.J., Ziminitzky B., DeMaso D.R., Bauman M.L., Bucci J.P. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 7(1):1997;9-15.
25. Yatham L.N., Lam R.W., Zis A.P. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy. Biological Psychiatry. 42:1997;24-29.
26. Yuwiler A., Shih J.C., Chen C.H., Ritvo E.R., Hanna G., Ellison G.W., King B.H. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of Autism and Developmental Disorders. 22(1):1992;33-45.